|
1
|
van Dam RM and Feskens EJ: Coffee
consumption and risk of type 2 diabetes mellitus. Lancet.
360:1477–1478. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ascherio A, Weisskopf MG, O'Reilly EJ,
McCullough ML, Calle EE, Rodriguez C and Thun MJ: Coffee
consumption, gender, and Parkinson's disease mortality in the
cancer prevention study II cohort: The modifying effects of
estrogen. Am J Epidemiol. 160:977–984. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ruhl CE and Everhart JE: Coffee and tea
consumption are associated with a lower incidence of chronic liver
disease in the United States. Gastroenterology. 129:1928–1936.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Je Y, Liu W and Giovannucci E: Coffee
consumption and risk of colorectal cancer: A systematic review and
meta-analysis of prospective cohort studies. Int J Cancer.
124:1662–1668. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu X, Bao Z, Zou J and Dong J: Coffee
consumption and risk of cancers: A meta-analysis of cohort studies.
BMC Cancer. 11:962011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tian C, Wang W, Hong Z and Zhang X: Coffee
consumption and risk of colorectal cancer: A dose-response analysis
of observational studies. Cancer Causes Control. 24:1265–1268.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang NJ, Lee KW, Kim BH, Bode AM, Lee HJ,
Heo YS, Boardman L, Limburg P, Lee HJ and Dong Z: Coffee phenolic
phytochemicals suppress colon cancer metastasis by targeting MEK
and TOPK. Carcinogenesis. 32:921–928. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lev Z, Kislitsin D, Rennert G and Lerner
A: Utilization of K-ras mutations identified in stool DNA for the
early detection of colorectal cancer. J Cell Biochem Suppl.
34:35–39. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Campbell SL, Khosravi-Far R, Rossman KL,
Clark GJ and Der CJ: Increasing complexity of Ras signaling.
Oncogene. 17(11 Reviews): 1395–1413. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hackel PO, Zwick E, Prenzel N and Ullrich
A: Epidermal growth factor receptors: Critical mediators of
multiple receptor pathways. Curr Opin Cell Biol. 11:184–189. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feinberg AP, Vogelstein B, Droller MJ,
Baylin SB and Nelkin BD: Mutation affecting the 12th amino acid of
the c-Ha-ras oncogene product occurs infrequently in human cancer.
Science. 220:1175–1177. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oka K: Pharmacological bases of coffee
nutrients for diabetes prevention. Yakugaku Zasshi. 127:1825–1836.
2007.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saud SM, Li W, Morris NL, Matter MS,
Colburn NH, Kim YS and Young MR: Resveratrol prevents tumorigenesis
in mouse model of Kras activated sporadic colorectal cancer by
suppressing oncogenic Kras expression. Carcinogenesis.
35:2778–2786. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luu C, Heinrich EL, Duldulao M, Arrington
AK, Fakih M, Garcia-Aguilar J and Kim J: TP53 and let-7a micro-RNA
regulate K-Ras activity in HCT116 colorectal cancer cells. PLoS
One. 8:e706042013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YY, Ren T, Cai YY and He XY: MicroRNA
let-7a inhibits the proliferation and invasion of nonsmall cell
lung cancer cell line 95D by regulating K-Ras and HMGA2 gene
expression. Cancer Biother Radiopharm. 28:131–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanic M, Yanowsky K, Rodriguez-Antona C,
Andrés R, Márquez-Rodas I, Osorio A, Benitez J and Martinez-Delgado
B: Deregulated miRNAs in hereditary breast cancer revealed a role
for miR-30c in regulating KRAS oncogene. PLoS One. 7:e388472012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
del Castillo MD, Ames JM and Gordon MH:
Effect of roasting on the antioxidant activity of coffee brews. J
Agric Food Chem. 50:3698–3703. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paur I, Balstad TR, Kolberg M, Pedersen
MK, Austenaa LM, Jacobs DR Jr and Blomhoff R: Extract of oregano,
coffee, thyme, clove, and walnuts inhibits NF-kappaB in monocytes
and in transgenic reporter mice. Cancer Prev Res (Phila).
3:653–663. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Paur I, Balstad TR and Blomhoff R: Degree
of roasting is the main determinant of the effects of coffee on
NF-kappaB and EpRE. Free Radic Biol Med. 48:1218–1227. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nicoli MC, Anese M, Parpinel MT,
Franceschi S and Lerici CR: Loss and/or formation of antioxidants
during food processing and storage. Cancer Lett. 114:71–74. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Daglia M, Papetti A, Gregotti C, Bertè F
and Gazzani G: In vitro antioxidant and ex vivo protective
activities of green and roasted coffee. J Agric Food Chem.
48:1449–1454. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fogliano V and Morales FJ: Estimation of
dietary intake of melanoidins from coffee and bread. Food Funct.
2:117–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nguyen HT, Dalmasso G, Müller S, Carrière
J, Seibold F and Darfeuille-Michaud A: Crohn's disease-associated
adherent invasive Escherichia coli modulate levels of microRNAs in
intestinal epithelial cells to reduce autophagy. Gastroenterology.
146:508–519. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goparaju CM, Blasberg JD, Volinia S,
Palatini J, Ivanov S, Donington JS, Croce C, Carbone M, Yang H and
Pass HI: Onconase mediated NFKβ downregulation in malignant pleural
mesothelioma. Oncogene. 30:2767–2777. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Isshiki M, Umezawa K and Tamura H: Coffee
induces breast cancer resistance protein expression in Caco-2
cells. Biol Pharm Bull. 34:1624–1627. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Galeone C, Turati F, La Vecchia C and
Tavani A: Coffee consumption and risk of colorectal cancer: A
meta-analysis of case-control studies. Cancer Causes Control.
21:1949–1959. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bøhn SK, Blomhoff R and Paur I: Coffee and
cancer risk, epidemiological evidence, and molecular mechanisms.
Mol Nutr Food Res. 58:915–930. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de Roock W, Claes B, Bernasconi D, De
Schutter J, Biesmans B, Fountzilas G, Kalogeras KT, Kotoula V,
Papamichael D, Laurent-Puig P, et al: Effects of KRAS, BRAF, NRAS,
and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy
in chemotherapy-refractory metastatic colorectal cancer: A
retrospective consortium analysis. Lancet Oncol. 11:753–762. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bravi F, Bosetti C, Tavani A, Bagnardi V,
Gallus S, Negri E, Franceschi S and La Vecchia C: Coffee drinking
and hepatocellular carcinoma risk: A meta-analysis. Hepatology.
46:430–435. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Friday BB and Adjei AA: K-ras as a target
for cancer therapy. Biochim Biophys Acta. 1756:127–144.
2005.PubMed/NCBI
|
